Alexander N. Katchman

Alexander N. Katchman

Auto-generated profile, based on publicly available information

Alexander N. Katchman

1,Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2024 in Circulation
Verified
Journal Article
Closed access
AKAlexander N. Katchman
Alexander N. Katchman
SZSergey I. Zakharov
Sergey I. Zakharov
MBMichael S. Bohnen
Michael S. Bohnen
AJAlejandro Sanchez Jimenez
Alejandro Sanchez Jimenez
JKJared S. Kushner
Jared S. Kushner
SMSteven O. Marx
Steven O. Marx

13 May 2025 in bioRxiv
Verified
Preprint
Open access
ARAaron Rodriques
Aaron Rodriques
GLGuoxia Liu
Guoxia Liu
AKAlex Katchman
Alex Katchman
SZSergey Zakharov
Sergey Zakharov
EWElaine Wan
Elaine Wan
JKJared Kushner
Jared Kushner
Background: Maladaptive changes in the function, expression and localization of proteins involved in calcium-handling worsen the impaired contractility of systolic heart failure (HF). Standard proteomics techniques require cell lysis and so are unable to characterize changes specific to the critical sub-cellular domain bounded by the T-tubule and the sarcoplasmic reticulum, known as the cardiac dyad. Traditional approaches are also less likely to capture low-affinity protein-protein interactions on lipid membranes. To improve our understanding of heart failure pathophysiology, we applied proximity proteomics to the cardiac dyad of mice with ischemic cardiomyopathy. Methods: Using two lines of transgenic mice expressing fusion proteins of the engineered ascorbate peroxidase APEX2 with subunits of the cardiac voltage gated calcium channel, Ca V 1.2, we labeled the dyad proteome of live, intact myocytes from healthy mice (N=6) and mice with coronary artery ligation HF (N=5) by peroxidase-catalyzed biotinylation. Quantitative mass spectrometry with isobaric tandem mass tags (TMT) was used to assess alterations in the local dyad proteome in myocytes from mice with chronic, remodeled HF. We subsequently generated a mouse with inducible cardiac overexpression of Galectin-1 to examine the effects of this protein on cardiac function and more specifically on the calcium-handling properties of mature myocytes, using cellular electrophysiology, calcium imaging, and echocardiography. Results: From mice with HF, we found significant enrichment of 43 proteins defined by their abundance and proximity to transgenic Ca V 1.2 α 1C channels, and a significant reduction in 22 proteins, out a of a total of 2326 proteins quantified. We also significantly enriched 286 proteins, and saw a reduction in 13 proteins, defined by proximity and abundance to Ca V 1.2 β 2B -subunits, out of a total 2236 proteins identified. Pathway analysis revealed HF is associated with increased abundance of components of the 26s proteasome and microtubules in the dyad, as well as the dimerizing, carbohydrate binding protein Galectin-1. Cardiac specific overexpression of Galectin-1 in healthy mice increases activation of Ca V 1.2 and the Ryanodine receptor and accelerates myocyte relaxation through phosphorylation of Phospholamban. Conclusions: Using proximity proteomics to examine the effects of HF in vivo , we find increased localization of Galectin-1 to the cardiac dyad, and that overexpression of Galectin-1 accelerates calcium kinetics in the heart.